Position in PFE
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$11,216,054
+$11,216,054 QoQ
Shares Held
465,783
Ownership
0.008%
of shares outstanding
% of Portfolio
3.37%
of 13F equity value
Holder Rank
#391
of 2,821 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Derivatives in PFE
reported options exposure · as of Jun 30, 2026CallValue
$12,040,000
CallShares
500,000
PutValue
$24,080,000
PutShares
1,000,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ADAPT Investment Managers SA holds $16,063,088 across 2 Drug Manufacturers - General names. PFE ranks #1 (69.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
This page
|
465,783 | $11,216,054 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
38,365 | $4,847,034 |
All Filings in PFE
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,040,000 | 500,000 | Call | Sole | 2026-07-27 | |
| 2026-06-30 | $11,216,054 | 465,783 | Shares | Sole | 2026-07-27 | |
| 2026-06-30 | $24,080,000 | 1,000,000 | Put | Sole | 2026-07-27 | |
| 2026-03-31 | $28,080,000 | 1,000,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $14,040,000 | 500,000 | Call | Sole | 2026-05-15 | |
| 2025-12-31 | $12,450,000 | 500,000 | Call | Sole | 2026-02-17 | |
| 2025-12-31 | $24,902,490 | 1,000,100 | Put | Sole | 2026-02-17 | |
| 2025-09-30 | $25,482,548 | 1,000,100 | Put | Sole | 2025-10-29 | |
| 2025-09-30 | $12,740,000 | 500,000 | Call | Sole | 2025-10-29 | |
| No filing history on record for this holder in this stock. | ||||||